Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
Business Of Biotech
00:00
The Origins of a Biotech Business
Ahmed Hamdi: Bayer wanted to divest their hematology programs. We were able to navigate through Bayer and actually our chief scientific officer and our chief development officer are both from Bayer. They're the parents of our drug conjugate platform. So having internal champions also helps. But you know, Dr. Bird and I have met with senior management and Bayer and I believe it was ASCO of 2019 and they felt that we can really take this very exciting technology to fruition.
Transcript
Play full episode
